Alfacell Corp (NASDAQOTH:ACEL.PK)

CAPS Rating: No stars

A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.

Recs

0
Player Avatar Quoinintl (< 20) Submitted: 1/24/2008 6:15:33 PM : Outperform Start Price: $2.60 ACEL.PK Score: -99.14

fda approval...oncanase!!

Featured Broker Partners


Advertisement